eHealth Resultados de beneficios anteriores
Pasado controles de criterios 0/6
eHealth ha aumentado sus beneficios a una tasa media anual de 5.1%, mientras que los beneficios de la industria de Insurance han experimentado un crecimiento anual de 13%. Los ingresos han ido disminuyendo a una tasa media de 1.8% al año.
Información clave
5.07%
Tasa de crecimiento de los beneficios
5.70%
Tasa de crecimiento del BPA
| Crecimiento de la industria Insurance | 8.02% |
| Tasa de crecimiento de los ingresos | -1.81% |
| Rentabilidad financiera | 4.11% |
| Margen neto | -1.88% |
| Próxima actualización de resultados | 06 May 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair
Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround
Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround
Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.EHTH: Higher 2025 Earnings Guidance Will Support Future Performance
Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower
Feb 10
EHTH: Enrollment Strength And Softer Competition Will Support Future Performance
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion
Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential
Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce
Dec 19EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential
Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.EHTH: Future Enrollment Trends Will Support Further Upside Potential
Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion
Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
Nov 08eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%
Oct 28eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Sep 03The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
May 15
Medicare Focus And AI Projects Will Improve Operations
Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet
Mar 16eHealth: Another Big Run, Lock In, And Run House Money
Feb 26Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost
Dec 23Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment
Dec 17A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb
Nov 08Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump
Aug 30We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation
Jun 06Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero eHealth. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 25 | 554 | -10 | 434 | 52 |
| 30 Sep 25 | 543 | 1 | 436 | 51 |
| 30 Jun 25 | 547 | -8 | 442 | 51 |
| 31 Mar 25 | 553 | -17 | 449 | 53 |
| 31 Dec 24 | 532 | -35 | 446 | 54 |
| 30 Sep 24 | 465 | -79 | 428 | 55 |
| 30 Jun 24 | 471 | -72 | 430 | 56 |
| 31 Mar 24 | 472 | -66 | 431 | 58 |
| 31 Dec 23 | 453 | -67 | 422 | 59 |
| 30 Sep 23 | 402 | -96 | 385 | 64 |
| 30 Jun 23 | 390 | -95 | 372 | 70 |
| 31 Mar 23 | 374 | -108 | 370 | 73 |
| 31 Dec 22 | 405 | -119 | 408 | 79 |
| 30 Sep 22 | 453 | -171 | 482 | 77 |
| 30 Jun 22 | 463 | -184 | 518 | 78 |
| 31 Mar 22 | 509 | -162 | 543 | 80 |
| 31 Dec 21 | 538 | -123 | 530 | 84 |
| 30 Sep 21 | 588 | -24 | 515 | 82 |
| 30 Jun 21 | 618 | 22 | 499 | 80 |
| 31 Mar 21 | 611 | 41 | 479 | 73 |
| 31 Dec 20 | 583 | 45 | 459 | 65 |
| 30 Sep 20 | 591 | 74 | 417 | 62 |
| 30 Jun 20 | 567 | 78 | 403 | 57 |
| 31 Mar 20 | 544 | 75 | 381 | 54 |
| 31 Dec 19 | 506 | 67 | 349 | 47 |
| 30 Sep 19 | 339 | 4 | 275 | 40 |
| 30 Jun 19 | 310 | 6 | 236 | 36 |
| 31 Mar 19 | 277 | 0 | 216 | 33 |
| 31 Dec 18 | 251 | 0 | 199 | 32 |
| 30 Sep 18 | 200 | 2 | 174 | 32 |
| 30 Jun 18 | 190 | 9 | 169 | 33 |
| 31 Mar 18 | 192 | 20 | 167 | 33 |
| 31 Dec 17 | 191 | 25 | 165 | 33 |
| 30 Sep 17 | 151 | -19 | 164 | 32 |
| 30 Jun 17 | 152 | -23 | 156 | 32 |
| 31 Mar 17 | 155 | -22 | 154 | 32 |
| 31 Dec 16 | 193 | 0 | 156 | 33 |
| 30 Sep 16 | 193 | 0 | 157 | 34 |
| 30 Jun 16 | 199 | 9 | 153 | 34 |
| 31 Mar 16 | 202 | 15 | 143 | 34 |
| 31 Dec 15 | 190 | -5 | 149 | 36 |
| 30 Sep 15 | 184 | -12 | 144 | 37 |
| 30 Jun 15 | 187 | -14 | 143 | 40 |
Ingresos de calidad: EHTH actualmente no es rentable.
Margen de beneficios creciente: EHTH actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: EHTH no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 5.1% por año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de EHTH en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: EHTH no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Insurance (35%).
Rentabilidad financiera
Alta ROE: EHTH tiene una rentabilidad financiera negativa (4.11%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/04/30 09:49 |
| Precio de las acciones al final del día | 2026/04/30 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
eHealth, Inc. está cubierta por 25 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Nathaniel Schindler | BofA Global Research |